Steven O’Day, MD and Jeffrey Weber, MD, PhD


Authored Items

Combination Checkpoint Blockade—It Is the New Standard for All Patients

April 2016, Vol. 5, No. 3 - Melanoma

According to Steven O’Day, MD, Professor of Medical Oncology, The John Wayne Cancer Institute, Santa Monica, CA, the essential arguments supporting combinations of checkpoint blockade immunotherapy as the standard for treating metastatic melanoma arise out of their high disease control rates, rapid deep responses, improved response rates, longer progression-free survival, [ Read More ]

Sign me up!